Navigation Links
Parkinson's Drugs Linked to Behavior Problems in Study
Date:3/29/2011

TUESDAY, March 29 (HealthDay News) -- Parkinson's disease drugs called dopamine agonists appear to cause impulse control problems in almost one-quarter of patients, says a new study.

Previous research has linked dopamine agonists, which include Mirapex (pramipexole) and Requip (ropinirole), to impulse control disorders, such as gambling addiction and hypersexuality, and to compulsive behaviors, such as binge eating, overspending and excessive computer use.

In this study, Mayo Clinic researchers analyzed Parkinson's disease patient records over two years.

"What we found was that as many as 22 percent of patients during that two-year period had a new-onset impulse control disorder," lead investigator and neurology fellow Dr. Anhar Hassan said in a Mayo Clinic news release.

The higher the dose of dopamine agonist, the more likely a patient was to develop an impulse control disorder, the researchers found.

"One in four patients who were on a medium therapeutic dose of the medication had an impulse control disorder. For patients who were taking a higher range of the medication, about one in three developed an impulse control disorder," Hassan said.

The study was recently published online in the journal Parkinsonism and Related Disorders.

Patients taking dopamine agonists and their families need to watch for any behavior changes, Hassan said. Reducing the dose or going off the medication usually resolves behavior problems within a few days to a month.

More information

We Move has more about drugs used to treat Parkinson's disease.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, March 23, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Discovery in liver cancer cells provides new target for drugs
2. Study Questions Rise in Use of Certain Cholesterol Drugs
3. Elderly victims of abuse often use alcohol or drugs, study says
4. Know your drugs: A primer for chemical and life science professionals is ACS Webinars topic
5. Researchers develop synthetic compound that may lead to drugs to fight pancreatic, lung cancer
6. MU chemist discovers shortcut for processing drugs
7. Popular drugs for common male health problems can affect their sexual health
8. Where are new schizophrenia drugs? Experts convene to explore genetic and epigenetic solutions
9. Doctors lax in monitoring potentially addicting drugs
10. Non-steroidal anti-inflammatory drugs linked to increased risk of erectile dysfunction
11. Seniors Concerned About Side Effects of Heart Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Parkinson's Drugs Linked to Behavior Problems in Study
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: